2026 NPPES data Neuroscience Clinical Nurse Specialist NPI 1801382775 APRN-CNS
Verify on CMS →

AMBERLEA BRADFORD ELLIOTT, APRN-CNS

Neuroscience Clinical Nurse Specialist in OKLAHOMA CITY, Oklahoma. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
43
Medicare Part D claims · Neuroscience Clinical Nurse Specialist avg: 591
Generic prescribing
74%
generic claims · 26% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$468.91
24 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

AMBERLEA BRADFORD ELLIOTT, APRN-CNS filed 43 Medicare Part D claims in 2023 as a Neuroscience Clinical Nurse Specialist in OKLAHOMA CITY, Oklahoma, prescribing 74% generic.

43
Part D claims, 2023
74%
generic prescribing
$468.91
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

AMBERLEA BRADFORD ELLIOTT, APRN-CNS's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

43 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about AMBERLEA BRADFORD ELLIOTT, APRN-CNS?

Quality data not reported

NPI registry status

Active

Issued 07/03/2018

NPI 1801382775

Primary specialty

Neuroscience Clinical Nurse Specialist

Rare

54 US NPIs in this specialty

Medicare Part D claims

43 93% vs specialty avg

2023 prescription claims

Specialty avg: 591

Specialty distribution in Oklahoma

How Neuroscience Clinical Nurse Specialist compares to other specialties among Oklahoma providers

Oklahoma providers

Neuroscience Clinical Nurse Specialist share within Oklahoma

1. Neuroscience Clinical Nurse Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neuroscience Clinical Nurse Specialist share within Oklahoma

Specialty board-certification context

Estimated specialty board-certified rate — Neuroscience Clinical Nurse Specialist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Neuroscience Clinical Nurse Specialist ABMS/AOA estimate

Est. board-certified rate (Neuroscience Clinical Nurse Specialist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Neuroscience Clinical Nurse Specialist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AMBERLEA BRADFORD ELLIOTT, APRN-CNS appears in the CMS NPPES registry as a Neuroscience Clinical Nurse Specialist provider holding APRN-CNS credentials at 4300 W MEMORIAL RD, OKLAHOMA CITY, OK, 73120, with a listed phone of (405) 486-8737. NPI 1801382775 was issued on 07/03/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BRADFORD ELLIOTT most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 43 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $8K in drug spend, split 26% brand-name and 74% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Neuroscience Clinical Nurse Specialist is a narrow specialty nationwide, with 54 enrolled providers across 23 states and an average of 591 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4300 W MEMORIAL RD
OKLAHOMA CITY, OK 73120

Provider Details

NPI 1801382775
Specialty Neuroscience Clinical Nurse Specialist
Credentials APRN-CNS
Gender Female
NPI Issued 07/03/2018

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for AMBERLEA BRADFORD ELLIOTT, APRN-CNS. Source: openpaymentsdata.cms.gov.

Total received

$469

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

AMBERLEA BRADFORD ELLIOTT, APRN-CNS — brand share 26.0%
Specialty average (est.)

26% brand-name claims vs 74% generic, on 43 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

43
Total Claims
$8K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
63
Total Day Supply
1,899
Brand vs Generic
26% brand / 74% generic
Brand Drug Cost
$8K
Generic Drug Cost
$345

Patient Demographics

Average Patient Age
78.1 years
Avg HCC Risk Score
1.35

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Eliquis
Apixaban
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neuroscience Clinical Nurse Specialist Overview

How AMBERLEA BRADFORD ELLIOTT, APRN-CNS fits within the Neuroscience Clinical Nurse Specialist landscape nationally.

54
Neuroscience Clinical Nurse Specialist Providers in US
23
States with Neuroscience Clinical Nurse Specialist
591
Avg Claims per Provider

AMBERLEA BRADFORD ELLIOTT, APRN-CNS's 43 claims are below the specialty average of 591.

Nearby Neuroscience Clinical Nurse Specialist Providers in Oklahoma

Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as BRADFORD ELLIOTT.

Compare Neuroscience Clinical Nurse Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is AMBERLEA BRADFORD ELLIOTT, APRN-CNS's specialty?
AMBERLEA BRADFORD ELLIOTT, APRN-CNS specializes in Neuroscience Clinical Nurse Specialist and practices in OKLAHOMA CITY, Oklahoma. Credentials: APRN-CNS.
How much does AMBERLEA BRADFORD ELLIOTT, APRN-CNS prescribe under Medicare Part D?
In 2023, AMBERLEA BRADFORD ELLIOTT, APRN-CNS wrote 43 Medicare Part D claims totaling $8K in drug costs for N/A beneficiaries.
Where is AMBERLEA BRADFORD ELLIOTT, APRN-CNS located?
AMBERLEA BRADFORD ELLIOTT, APRN-CNS is located at 4300 W MEMORIAL RD, OKLAHOMA CITY, OK, 73120. Phone: (405) 486-8737.
What is AMBERLEA BRADFORD ELLIOTT, APRN-CNS's NPI number?
AMBERLEA BRADFORD ELLIOTT, APRN-CNS's National Provider Identifier (NPI) is 1801382775, issued on 07/03/2018.
Does AMBERLEA BRADFORD ELLIOTT, APRN-CNS prescribe more brand-name or generic drugs?
AMBERLEA BRADFORD ELLIOTT, APRN-CNS's prescribing is 26% brand-name and 74% generic drugs by claim count, with $8K in brand drug costs.
How many Neuroscience Clinical Nurse Specialist providers are there in the US?
There are 54 Neuroscience Clinical Nurse Specialist providers across 23 states in the US. The average Neuroscience Clinical Nurse Specialist provider writes 591 Medicare Part D claims per year.
What drugs does AMBERLEA BRADFORD ELLIOTT, APRN-CNS prescribe most often?
Based on 2023 Medicare Part D data, AMBERLEA BRADFORD ELLIOTT, APRN-CNS's most frequently prescribed drugs include Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AMBERLEA BRADFORD ELLIOTT, APRN-CNS accept Medicare?
AMBERLEA BRADFORD ELLIOTT, APRN-CNS appears in CMS Medicare data with 43 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AMBERLEA BRADFORD ELLIOTT, APRN-CNS's credentials?
AMBERLEA BRADFORD ELLIOTT, APRN-CNS's NPI is 1801382775 with credentials APRN-CNS. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology